|Year : 2022 | Volume
| Issue : 4 | Page : 276-280
Anabasis articulata exerts an anti-arthritic effect on adjuvant-induced arthritis in rats
Zaid Hamzah Abdulhusain1, Makarim A Mahdi2, Waleed K Abdulsahib3, Layth S Jasim2
1 Department of Pharmaceutical Chemistry, College of Pharmacy, University of Al-Qadisiyah, Al Diwaniyah, Iraq
2 Department of Chemistry, College of Education, University of Al-Qadisiyah, Al Diwaniyah, Iraq
3 Department of Pharmacology and Toxicology, College of Pharmacy, Al Farahidi University, Baghdad, Iraq
|Date of Submission||11-Jun-2022|
|Date of Decision||13-Jul-2022|
|Date of Acceptance||18-Jul-2022|
|Date of Web Publication||10-Oct-2022|
Dr. Waleed K Abdulsahib
Department of Pharmacology and Toxicology, College of Pharmacy, Al Farahidi University, Baghdad 10070
Source of Support: None, Conflict of Interest: None
Anabasis articulata (AA) is commonly found in the Iraqi desert and is utilized in traditional medicine to cure kidney infections, eczema, fever, and diabetes. The paper aimed to identify the anti-arthritic impact of AA on arthritis models in rats. Complete Freund's Adjuvant (CFA) was used intradermally (ID) for the induction of arthritis. The author classified animals into four groups randomly: The first group took normal saline (control), the second group received AA orally for 14 days before induction and continue 17 days after induction, the third group was induced by CFA and received normal saline orally (model group), and the fourth group took AA orally 17 days after induction. AA administration increased body weight (BW) but decreased arthritis index (AI), histopathological scores, and vascular endothelial growth factor expression in synovial cells. AA has an important antiangiogenesis and anti-arthritic activity in arthritis model rats.
Keywords: Anabasis articulate, adjuvant-induced arthritis, vascular endothelial growth factor, Arthritis
|How to cite this article:|
Abdulhusain ZH, Mahdi MA, Abdulsahib WK, Jasim LS. Anabasis articulata exerts an anti-arthritic effect on adjuvant-induced arthritis in rats. J Adv Pharm Technol Res 2022;13:276-80
|How to cite this URL:|
Abdulhusain ZH, Mahdi MA, Abdulsahib WK, Jasim LS. Anabasis articulata exerts an anti-arthritic effect on adjuvant-induced arthritis in rats. J Adv Pharm Technol Res [serial online] 2022 [cited 2022 Nov 28];13:276-80. Available from: https://www.japtr.org/text.asp?2022/13/4/276/358217
| Introduction|| |
Rheumatoid arthritis (RA) is a late-stage multisystem disease that primarily affects the synovium, resulting in synovium loss, articular cartilage loss, and near-joint erosion. The disease has a natural history of progressive joint damage and deformities, with extra-articular signs appearing in a small number of people. Continuous treatment strategies have successfully provided significant clinical benefits to the majority of patients, particularly when the disease is diagnosed and treated early. In developed countries, the prevalence of RA is generally stated more in the male population than in females. Four groups exist for the treatment of the disease, comprising anti-inflammatory nonsteroidal drugs, antirheumatic disease-modifying drugs, steroidal anti-inflammatory drugs, and biological agents that are frequently indicated for the management of RA. CFA is the best model for producing arthritis in animals because it closely resembles human arthritis in many ways.
Anabasis articulata (AA) is commonly found in the Iraqi desert. It is widely used in folk medicine for the management of elevated glucose levels, lowering high temperatures, inflammatory skin conditions, and some kidney infections., In a previous study, the LD50 value of AA methanol extract was found to be 26.18 g/kg, indicating that the herb is safe to use for medical purposes. AA has flavones, alkaloids, tannins, saponins, and resins. The three major constituents detected through gas chromatography-mass spectrometry (GC-MS) analysis of methanol extract were glycine, scopoletin, and 2-methoxy 4-vinylphenol, with a minor one was 1,2-dimethylpiperidine. Several biological activities were attributed to saponins, flavones, and alkaloids, such as their antidiabetic, anti-arthritic, and antitumoral properties. The study's purpose is the assessment of the anti-arthritic and anti-inflammatory impacts of AA on rats.
| Materials and Methods|| |
Plant extract preparation
Stems of AA were obtained from a local herbal apothecary in Baghdad. The authentication of the herb was performed under the supervision of Dr. Ibrahim Salih Abbas, Professor (Ph.D.) in medicinal plants, Pharmacognosy Department, Al-Mustansiryah University, Iraq. A specimen (99,334) of the plant was put down at the Herbarium of the Faculty of Pharmacy, Al Farahidi University. The maceration process (cold method) was used for the extraction, after which the substance was concentrated by the rotary evaporator with a vacuum (Buchi, Switzerland) to get the final crude extract.
Chemical and reagents
Complete Freund's Adjuvant, ethyl ether, formalin, hematoxylin (H), and eosin (E) stain were purchased from Sigma-Aldrich (Germany). Santa Cruz Biotechnology, Inc. Europe provided the primary antibody of vascular endothelial growth factor (VEGF) (C-1): sc-7269 and the detection kit of secondary immune peroxidase (ImmunoCruzTM mouse labeled streptavidin–biotin Staining System: sc-2050).
Two-month-old male rats were obtained from Al-Nahrain University (Baghdad, Iraq). The animals were placed at 22 ± 3°C in a light/dark cycle for 12 h with softwood shavings as bedding. They were provided easy access to water and were fed a standard commercial pellet diet. All animal experiments were designed in conformity with the Animal Ethics Committee of Al-Nahrain University-College of Medicine under the number (NUCM-6622). A 100 mg/kg dose of the tested herb was administered once daily through intragastric gavage. The experimental design consisted of four groups (each with eight animals). Group 1: rats were injected with normal saline ID and given DW orally (control). Group 2: rats were given AA orally for 14 days before induction and continued until day 17 after immunization. Group 3: rats were injected with CFA ID and received DW orally (model group). Group 4: rats were given AA on the same day of induction and continued until day 17 after immunization. Arthritis was induced by ID injection of 50 μl CFA at the tail's base. For additional analyses, on day 17 of postimmunization, all animals were killed under anesthesia with ethyl ether.
Clinical arthritis assessment
Rats were evaluated every 2 days starting on the 7th day following immunization for clinical indicators, such as AI and BW.
AI was calculated by examining and noting the severity of pathological changes in all body joints. The five graded scales of arthritis index were used, with (0): no swelling, (1) little toe joint swelling, (2) swelling on the metatarsophalangeal joint and foot, (3) hind paw below ankle swelling, and (4) the hind paw including ankle swelling. Each rat was assigned a point value, with a maximum possible score of 12 points.
Measurement of the body weight of the rats
BW of all groups was measured every 2 days for 14 days starting on day 7 after immunization (onset of arthritis).
All animals were euthanized after 17 days of immunization. The hind paws above the joint of the knee were amputated and embedded in a 10% neutral buffered formalin solution. Before embedding in paraffin and sectioning in the midsagittal plane, paws were decalcified. Hematoxylin and eosin were used to stain the tarsal joint articulation slices, which were then inspected under a microscope.
The assessment of the arthritis histological changes
The following scoring system was used by the observer to evaluate the cartilage and bone destruction: In terms of mononuclear cell infiltration (MCI), a score of 3, 2, 1, and 0 was given for severe, moderate, mild, and no infiltration, respectively. To assess the destruction of the bone and cartilage caused by pannus formation (PF): a score of 3, 2, 1, and 0 was given for severe change (invasion of the pannus into the subchondral bone), moderate change (pannus invasion into cartilage/subchondral bone), minor change (pannus invasion within cartilage), and no change, respectively. Furthermore, the observer used the following scores to assess vascularity (V): 3 indicated many blood vessels; 2 indicated some blood vessels; 1 indicated a small number of blood vessels; and 0 indicated almost no blood vessels.
Immunohistochemistry of vascular endothelial growth factor in joint synovium
By immunohistochemistry, VEGF (C-1): diluted 1:100 sc-7269 was utilized to detect the 121, 165, and 189 amino acid splice variants of rat VEGF (including paraffin-embedded sections). ImmunoCruz Staining System used a horseradish peroxidase–streptavidin complex to tissue slices that were formalin fixed and paraffin embedded.
Immunohistochemical stain evaluation
Brown cytoplasmic staining of lining synoviocytes indicated positive immunohistochemical staining for VEGF. These scoring methods were used to quantify VEGF expressions in tissue specimens of all groups. Score 1 indicated <10% positive lining synoviocytes, score 2 indicated 10%–25% positive cells, score 3 indicated 25%–50% positive cells, and score 4 indicated more than 50% positive cells.
One-way analysis of variance was used to compare the groups. Then, a Tukey test comparison was made. For statistical analysis, the authors used Statistical Package for the Social Sciences (SPSS) 23.0 software, and set the significance level at (P < 0.05). The outcomes were presented in the form of mean ± standard deviation of the mean.
| Results|| |
When compared to the induced group, daily administration of AA decreased the arthritis score significantly for both treated (P = 0.0034) and prophylaxis (P = 0.0023) groups. These findings suggest that AA prevented the onset and reduced arthritis's severity in adjuvant-induced arthritis (AIA) rats, as shown in [Figure 1]a.
|Figure 1: Inhibition of clinical arthritis by AA administration to AIA rats, (a) represents AI, and (b) represents BW (n = 8). Data are shown as (mean ± SD), (n = 8). **P < 0.01 compared to prophylactic and treated compared to the model group. AA: Anabasis articulata, AIA: Adjuvant-induced arthritis, AI: Arthritis index, BW: Body weight, SD: Standard deviation|
Click here to view
When compared to the induced group, daily administration of AA to the prophylaxis group increased (P = 0.0042) BW significantly. Furthermore, the rat weight of the AA-treated group had a more significant (P = 0.0013) increase. The findings denoted that administrating AA orally inhibited inflammatory-induced body weight loss in AIA rats, as shown in [Figure 1]b.
Histological examination of the foot joints performed on day 17 illustrated that rats in both groups 2 and 4 showed lower scores for MCI, V, and PF in synovial tissues than those in Group 3 (P < 0.01; [Figure 2]). Furthermore, comparing the above groups with the control group showed no significant differences (P > 0.05). These findings indicated anti-inflammatory and antiangiogenic effects of AA, as shown in [Figure 3].
|Figure 2: Effect of AA on histopathological scores of the hind limb illustrate: (a): MCI scores, (b) PF scores, and (c): V scores. Data are shown as (mean ± SD), (n = 8). *P < 0.01 compared to the prophylactic and treated compared to the model group. AA: Anabasis articulata, MCI: Mononuclear cell infiltration, PF: Pannus formation, SD: Standard deviation|
Click here to view
|Figure 3: Effect of AA on histological changes on joint tissue of AIA rats, (a): Group 1 shows zero histological scores, (b): Group 2 shows mild MCI and cartilage and bone destruction by PF and few V, (c): Group 3 shows severe MCI and destruction of cartilage and bone by PF and high V, (d): Group 4 shows mild MCI and change of cartilage and bone by PF and a few V. H and E stain (×40), J: joint space, C: cartilage, BM: bone marrow and B: bone. MCI is represented by (black arrow), PF pannus (blue arrow), and V (red arrow): AA: Anabasis articulata, AIA: Adjuvant-induced arthritis, MCI: Mononuclear cell infiltration, PF: Pannus formation|
Click here to view
Expression of vascular endothelial growth factor in synovial tissues
The expression of VEGF dramatically increased in the synoviocytes of induced rats (immunohistochemical score 3.8 ± 0.11). This increase was significant compared to the control group (1.22 ± 0.14) (P = 0.00076). Furthermore, a significant decrease was observed in VEGF expression in synoviocytes in both the prophylaxis (1.66 ± 0.16) and treated groups, as shown in [Figure 4] and [Figure 5].
|Figure 4: Effect of AA on the expression of VEGF score (n = 8). *P < 0.05 in the case of comparison of the prophylactic and treated group to the induction (model) group. AA: Anabasis articulata, VEGF: Vascular endothelial growth factor|
Click here to view
|Figure 5: Effect of AA on IE of VEGF, (a): Section of joint tissue of Group 1 showing positive IE of VEGF in less than 10% of lining synoviocytes, (b) Is a section from joint tissue of Group 2 showing positive IE of VEGF between 10% and 25% of lining synoviocytes. (c) Represents a section of joint tissue of Group 3 that shows positive IE of VEGF over 50% of lining synoviocytes: scores 4, and (d) Represents a section of joint tissue of Group 4 showing positive IE of VEGF between 10% and 25% of lining synoviocytes: score 2. AA: Anabasis articulata, IE: Immunohistochemistry expression, VEGF: Vascular endothelial growth factor|
Click here to view
| Discussion|| |
The induction of arthritis by CFA is a commonly used model because it shares many immunological and clinical similarities with human arthritis. CFA causes obvious swelling of the rat's ankle, hind paw, and toe, with the greatest inflammation occurring between days 11 and 17, as well as an obvious reduction in body weight in comparison to the control group. BW variation in CFA-induced rats is an important feature for assessing the medicinal agent's response and the disease's interval in terms of inflammation. Arthritis induction was also found to cause an increase in arthritis index score and paw swelling. In CFA-induced rats, paw swelling denotes the strength of inflammation, whereas paw swelling depression after treatment denotes the drug's anti-arthritic activity., Prophylaxis administration of AA results in an obvious increase in BW and a well-meaning decrease in clinical parameters, such as a decline in the swelling of the ankle, toe, and hind paw. Administrating AA to the treatment group increased BW and significantly decreased the swelling of the toe, hind paw, and ankle. In a previous study, GC-MS analysis of AA revealed the presence of glycine, coumarin, alkaloid, and phenol., Pan et al. demonstrated that scopoletin, one constituent of AA, improved clinical symptoms of arthritis in rats. Wang et al. demonstrated that plants with a high phenol content inhibited arthritis caused by CFA. Li et al. demonstrated that glycine could prevent peptidoglycan polysaccharide-induced reactive arthritis in rats. All of the above findings support our findings on the anti-arthritic effect of AA. It has recently been established that VEGF has a major role in RA. The amount of VEGF expressed in tissues and synovial fluid correlates with the grade of joint damage severity. VEGF expression begins early and continues throughout the disease course., Nonspecific angiogenesis inhibitors produced significant clinical benefits in a variety of models of arthritis, including ovalbumin-induced arthritis and collagen-induced arthritis (CIA). Miotla and colleagues demonstrated a rapid reduction in clinical symptoms in CIA after inhibiting VEGF activity. The suppression of angiogenesis and inflammation within the joint, facilitated by VEGF, is elegant healing in arthritis because VEGF is found in the synovial fluid and synovium of people with RA. AA effectively inhibits VEGF expression in synoviocyte cells in both the prophylaxis and treated groups when compared to the model group and near normal when compared to the control group. These outcomes agree with previous studies that demonstrated the antiangiogenic effect of AA accomplished in rat aorta ring and chick chorioallantoic membrane assays., Although we must determine which explanation is precise if we are to form better arthritis treatments. The complete inhibition of the disease is very promising for detecting suitable healing agents for this incapacitating disease.
| Conclusions|| |
The methanolic extract of AA demonstrated clear protective and anti-arthritic effects in rats by CFA and held promise for future RA treatment.
We would like to thank the Pharmacology Department in Medicine College – the Al-Nahrain University for assistance in accomplishing this study.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
van Delft MA, Huizinga TW. An overview of autoantibodies in rheumatoid arthritis. J Autoimmun 2020;110:102392.
DeMizio DJ, Geraldino-Pardilla LB. Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis. Rheumatol Ther 2020;7:19-33.
Xu Y, Wu Q. Prevalence trend and disparities in rheumatoid arthritis among US adults, 2005-2018. J Clin Med 2021;10:3289.
Lalor AF, Brooker JE, Rozbroj T, Whittle SL, Hill CL, Rowett D, et al
. Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies. Semin Arthritis Rheum 2022;55:151988.
Schinnerling K, Rosas C, Soto L, Thomas R, Aguillón JC. Humanized mouse models of rheumatoid arthritis for studies on immunopathogenesis and preclinical testing of cell-based therapies. Front Immunol 2019;10:203.
Al-Joufi FA, Jan M, Zahoor M, Nazir N, Naz S, Talha M, et al
. Anabasis articulata (Forssk.) Moq: A good source of phytochemicals with antibacterial, antioxidant, and antidiabetic potential. Molecules 2022;27:3526.
Abdulsahib WK. The effect of Anabasis articulata stems extract on lowering intraocular pressure in the glaucoma rat model (Conference Paper). Iraqi J Pharm Sci 2021;30:1-8.
Abudalsahib W, Abd A, Jumaa B. Antiangiogenic activity of Iraqi anabasis articulata stems in vivo
study. Int J Sci Res 2016;5:220-6.
Abdulsahib K, Abdulkareem A, Ban Jumaa Q, Hayder S. Antiangiogenesis and antioxidant effect of Anabasis articulata stems extracts. Int J Pharm Sci Rev Res 2016;41:88-94.
Goyal A, Agrawal N. Quercetin: A potential candidate for the treatment of arthritis. Curr Mol Med 2022;22:325-35.
Chyuan IT, Tsai HF, Liao HJ, Wu CS, Hsu PN. An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis. Cell Mol Immunol 2018;15:846-57.
Rutgers M, van Pelt MJ, Dhert WJ, Creemers LB, Saris DB. Evaluation of histological scoring systems for tissue-engineered, repaired and osteoarthritic cartilage. Osteoarthritis Cartilage 2010;18:12-23.
Ao L, Gao H, Jia L, Liu S, Guo J, Liu B, et al
. Matrine inhibits synovial angiogenesis in collagen-induced arthritis rats by regulating HIF-VEGF-Ang and inhibiting the PI3K/Akt signaling pathway. Mol Immunol 2022;141:13-20.
Taylor PC. VEGF and imaging of vessels in rheumatoid arthritis. Arthritis Res 2002;4 Suppl 3:S99-107.
Billiau A, Matthys P. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 2001;70:849-60.
Naik SR, Wala SM. Arthritis, a complex connective and synovial joint destructive autoimmune disease: Animal models of arthritis with varied etiopathology and their significance. J Postgrad Med 2014;60:309-17.
] [Full text]
Pan R, Gao XH, Li Y, Xia YF, Dai Y. Anti-arthritic effect of scopoletin, a coumarin compound occurring in Erycibe obtusifolia Benth stems, is associated with decreased angiogenesis in synovium. Fundam Clin Pharmacol 2010;24:477-90.
Wang WQ, Wang FH, Qin WX, Liu HY, Lu B, Chung C, et al
. Joint antiangiogenic effect of ATN-161 and anti-VEGF antibody in a rat model of early wet age-related macular degeneration. Mol Pharm 2016;13:2881-90.
Li X, Bradford BU, Wheeler MD, Stimpson SA, Pink HM, Brodie TA, et al
. Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: Role for glycine-gated chloride channel. Infect Immun 2001;69:5883-91.
Bäckström NF, Dahlgren UI. Bystander suppression of collagen-induced arthritis in mice fed ovalbumin. Arthritis Res Ther 2004;6:R151-60.
Miotla J, Maciewicz R, Kendrew J, Feldmann M, Paleolog E. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest 2000;80:1195-205.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]